Director/PDMR Shareholding

RNS Number : 3347I

GlaxoSmithKline PLC

01 July 2013

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 28 June 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

	Ordinary Shares	ADSs
Sir Andrew Witty	6,151.624
Dr M M Slaoui		1,897.363
Mr S Dingemans	2,706.794
Mr S M Bicknell	591.492
Mr R G Connor	1,159.796
Mrs D P Connelly		785.783
Mr S A Hussain	2,319.605
Mr W C Louv		556.586
Mr D S Redfern	889.177
Ms C Thomas	1,256.452
Mr P C Thomson	599.221
Mr D E Troy		1,187.662
Dr P J T Vallance	2,706.218
Ms E Walmsley	1,546.408
Mr C Weber	552.523
Mrs V A Whyte	165.826

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 July 2013

 

END

 

 

RDSEFLFBXDFEBBL